Design and Synthesis of Aspartic and Serine Protease Inhibitors : Targeting the BACE-1 and the HCV NS3 Protease
This thesis describes work done to design and synthesize protease inhibitors, with the intention of developing therapeutic agents for Alzheimer’s disease (AD) and the chronic liver condition caused by infection of the hepatitis C virus (HCV). AD is the most common form of dementia, and HCV infection...
Main Author: | Wångsell, Fredrik |
---|---|
Format: | Doctoral Thesis |
Language: | English |
Published: |
Uppsala universitet, Institutionen för läkemedelskemi
2009
|
Subjects: | |
Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-108985 http://nbn-resolving.de/urn:isbn:978-91-554-7623-6 |
Similar Items
-
Design and Synthesis of Serine and Aspartic Protease Inhibitors
by: Wångsell, Fredrik
Published: (2006) -
Design and Synthesis of Inhibitors Targeting the Hepatitis C Virus NS3 Protease : Focus on C-Terminal Acyl Sulfonamides
by: Rönn, Robert
Published: (2007) -
Synthetic bulky NS4A peptide variants bind to and inhibit HCV NS3 protease
by: Moustafa E. El-Araby, et al.
Published: (2020-07-01) -
Variability and resistance mutations in the hepatitis C virus NS3 protease in patients not treated with protease inhibitors
by: Luciana Bonome Zeminian, et al.
Published: (2013-02-01) -
Variability and resistance mutations in the hepatitis C virus NS3 protease in patients not treated with protease inhibitors
by: Luciana Bonome Zeminian, et al.
Published: (2013-02-01)